Skip to main content
NVDA+0.05%AAPL+0.11%GOOGL-1.07%MSFT+0.55%AMZN+0.33%TSM+1.54%SPCX+1.89%META+0.52%AVGO+0.52%TSLA+0.18%SKHY+3.45%MU-0.41%LLY+0.48%BRK-B+0.31%AMD+1.34%JPM-3.42%WMT+2.49%V-2.14%ASMLa+0.18%XOM+0.25%JNJ-0.10%INTC+1.71%0700.HK-2.35%MA-2.07%ABBV+0.32%1398.HK0.00%ORCL+0.38%CSCO-4.50%CVX-0.61%COST+0.10%BAC-3.04%LRCX+2.87%KO+1.71%AMAT+1.77%AP2d+1.12%CAT-1.04%DELL-4.57%ARM+3.19%PG+1.46%0005.HK+0.13%HSBA.L+0.87%UNH-1.22%GE+0.07%3988.HK-0.33%MS-2.87%1816.HK-0.48%HD+2.74%NFLX-1.64%0939.HK-0.82%PM+1.47%GBPUSD-0.69%USDCAD+0.68%GBPCHF-0.66%CADCHF-0.65%USDJPY+0.63%CHFJPY+0.62%EURUSD-0.60%EURCHF-0.56%USDPLN+0.51%AUDUSD-0.50%AUDCHF-0.47%USDMXN+0.47%USDZAR+0.43%GBPTRY+0.41%NZDUSD-0.36%GBPNZD-0.33%NZDCAD+0.33%GBPHKD+0.32%NZDCHF-0.30%NZDJPY+0.30%GBPMXN-0.28%EURNZD-0.28%NZDSGD-0.28%EURHKD-0.27%USDDKK+0.27%USDTHB-0.26%USDNOK+0.26%EURPLN+0.24%PLNJPY-0.22%AUDSGD-0.21%GBPAUD-0.18%USDSGD+0.18%EURZAR+0.17%AUDCAD+0.17%USDILS+0.16%AUDNZD-0.16%USDTRY+0.15%GBPSGD-0.14%USDSEK+0.14%EURCNH-0.14%USDCNH+0.14%AUDJPY+0.13%EURSEK-0.13%SGDJPY+0.13%AUDNOK-0.12%AUDDKK-0.11%GBPZAR+0.11%EURGBP+0.10%EURSGD-0.09%EURCZK+0.08%EURAUD-0.08%CHFSEK-0.07%CADJPY-0.06%GBPJPY-0.05%EURCAD+0.05%NOKJPY+0.05%CHFNOK+0.04%USDCOP-0.04%CHFSGD-0.04%USDHKD-0.02%EURJPY+0.02%USDCHF+0.02%EURNOK-0.01%NZDMXN+0.01%EURDKK0.00%GBPCAD0.00%XAGUSD-2.42%GAGUSD-2.42%XPTUSD-2.38%SUGAR-1.36%C1-1.19%W1-1.10%COCOA-1.08%HG1-1.02%GAUUSD-0.91%XAUUSD-0.91%XNGUSD+0.87%UKOIL+0.71%BTCUSD-0.34%ETHUSD-0.67%USDTUSD-0.02%XRPUSD-1.03%SOLUSD-0.99%TRXUSDT+0.33%ZECUSDT+0.14%DOGEUSD-0.69%XMRUSDT-0.85%LINKUSD-1.31%BCHUSDT+2.86%XLMUSD-2.36%UNIUSD+0.09%LTCUSD-0.55%HBARUSDT-1.63%SUIUSD-1.17%TONUSD+16.86%TAOUSDT-1.46%AAVEUSD+0.73%DOTUSDT-4.15%ICPUSDT+0.20%ARBUSDT-3.82%ONDOUSDT-2.35%WLDUSDT-3.91%JUPUSDT-2.59%ATOMUSDT-1.94%INJUSDT+1.01%STXUSDT-2.74%FETUSDT-2.85%TIAUSDT+0.90%SEIUSDT-1.67%PYTHUSDT-1.44%IMXUSDT+0.67%GRTUSDT+4.72%OPUSDT+0.93%WIFUSDT-2.16%IOTAUSDT-0.96%POLUSDT-0.44%FARTCOINUSDT-4.53%AXSUSDT+0.79%EOSUSDT+0.34%DYDXUSDT-0.98%ORDIUSDT-1.74%GALAUSDT-0.70%NOTUSDT-2.88%RONINUSDT-0.79%NVDA+0.05%AAPL+0.11%GOOGL-1.07%MSFT+0.55%AMZN+0.33%TSM+1.54%SPCX+1.89%META+0.52%AVGO+0.52%TSLA+0.18%SKHY+3.45%MU-0.41%LLY+0.48%BRK-B+0.31%AMD+1.34%JPM-3.42%WMT+2.49%V-2.14%ASMLa+0.18%XOM+0.25%JNJ-0.10%INTC+1.71%0700.HK-2.35%MA-2.07%ABBV+0.32%1398.HK0.00%ORCL+0.38%CSCO-4.50%CVX-0.61%COST+0.10%BAC-3.04%LRCX+2.87%KO+1.71%AMAT+1.77%AP2d+1.12%CAT-1.04%DELL-4.57%ARM+3.19%PG+1.46%0005.HK+0.13%HSBA.L+0.87%UNH-1.22%GE+0.07%3988.HK-0.33%MS-2.87%1816.HK-0.48%HD+2.74%NFLX-1.64%0939.HK-0.82%PM+1.47%GBPUSD-0.69%USDCAD+0.68%GBPCHF-0.66%CADCHF-0.65%USDJPY+0.63%CHFJPY+0.62%EURUSD-0.60%EURCHF-0.56%USDPLN+0.51%AUDUSD-0.50%AUDCHF-0.47%USDMXN+0.47%USDZAR+0.43%GBPTRY+0.41%NZDUSD-0.36%GBPNZD-0.33%NZDCAD+0.33%GBPHKD+0.32%NZDCHF-0.30%NZDJPY+0.30%GBPMXN-0.28%EURNZD-0.28%NZDSGD-0.28%EURHKD-0.27%USDDKK+0.27%USDTHB-0.26%USDNOK+0.26%EURPLN+0.24%PLNJPY-0.22%AUDSGD-0.21%GBPAUD-0.18%USDSGD+0.18%EURZAR+0.17%AUDCAD+0.17%USDILS+0.16%AUDNZD-0.16%USDTRY+0.15%GBPSGD-0.14%USDSEK+0.14%EURCNH-0.14%USDCNH+0.14%AUDJPY+0.13%EURSEK-0.13%SGDJPY+0.13%AUDNOK-0.12%AUDDKK-0.11%GBPZAR+0.11%EURGBP+0.10%EURSGD-0.09%EURCZK+0.08%EURAUD-0.08%CHFSEK-0.07%CADJPY-0.06%GBPJPY-0.05%EURCAD+0.05%NOKJPY+0.05%CHFNOK+0.04%USDCOP-0.04%CHFSGD-0.04%USDHKD-0.02%EURJPY+0.02%USDCHF+0.02%EURNOK-0.01%NZDMXN+0.01%EURDKK0.00%GBPCAD0.00%XAGUSD-2.42%GAGUSD-2.42%XPTUSD-2.38%SUGAR-1.36%C1-1.19%W1-1.10%COCOA-1.08%HG1-1.02%GAUUSD-0.91%XAUUSD-0.91%XNGUSD+0.87%UKOIL+0.71%BTCUSD-0.34%ETHUSD-0.67%USDTUSD-0.02%XRPUSD-1.03%SOLUSD-0.99%TRXUSDT+0.33%ZECUSDT+0.14%DOGEUSD-0.69%XMRUSDT-0.85%LINKUSD-1.31%BCHUSDT+2.86%XLMUSD-2.36%UNIUSD+0.09%LTCUSD-0.55%HBARUSDT-1.63%SUIUSD-1.17%TONUSD+16.86%TAOUSDT-1.46%AAVEUSD+0.73%DOTUSDT-4.15%ICPUSDT+0.20%ARBUSDT-3.82%ONDOUSDT-2.35%WLDUSDT-3.91%JUPUSDT-2.59%ATOMUSDT-1.94%INJUSDT+1.01%STXUSDT-2.74%FETUSDT-2.85%TIAUSDT+0.90%SEIUSDT-1.67%PYTHUSDT-1.44%IMXUSDT+0.67%GRTUSDT+4.72%OPUSDT+0.93%WIFUSDT-2.16%IOTAUSDT-0.96%POLUSDT-0.44%FARTCOINUSDT-4.53%AXSUSDT+0.79%EOSUSDT+0.34%DYDXUSDT-0.98%ORDIUSDT-1.74%GALAUSDT-0.70%NOTUSDT-2.88%RONINUSDT-0.79%
AO

Aktis Oncology, Inc. (AKTS)

NASDAQ • Healthcare

$22.11
+$0.67 (+3.2%)
Market closed

Last close at September 22, 2026 at 20:00 UTC

Open$21.69
Day Range$21.45 - $22.22
Avg. Volume (3M)472.7K
Market Cap$1.1B
52 Week Range
$14.72$34.19
Next EarningsIn 50 daysNov 12, 2026

Metrics Over Time

Where the Money Goes

Q4 2025
Revenueeverything earned$6.4M100%
Gross Profitminus cost of goods$6.4M100%

Fundamentals & Financials

Revenue (TTM)
$10M
Net Income (TTM)
-$73.1M
EPS (TTM)
-$1.05
ROA (TTM)
-13.12%
Current Ratio
7.37

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+15.8%Q1 2026-$18.19
-22.6%Q2 2026-$0.38
-2.2%Q3 2026-$0.44
Next

Nov 12

in 50 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Miss -2.2%

Aktis Oncology trailed consensus on EPS in the second fiscal quarter of 2026, reported August 13, 2026, with EPS of -$0.44 versus the -$0.43 estimate (difference -$0.01). Revenue came in at roughly $3.4 million, and gross profit of about $2.5 million left gross margin at ~74%, while the company posted operating income of roughly -$28.9 million alongside net income of about -$24.1 million. Aktis remains focused on advancing its targeted radiopharmaceutical therapies built on its miniprotein radioconjugate platform rather than operating as a commercial-stage drug seller. For the next period, consensus calls for EPS of -$0.11 on revenue of $8.2 million.

View full earnings history

About Aktis Oncology, Inc.

Aktis Oncology, Inc. is a NASDAQ-listed healthcare company in biotechnology that develops targeted radiopharmaceutical therapies for cancer treatment. It operates as a clinical-stage biotech business rather than a commercial drug seller, with work centered on a proprietary miniprotein radioconjugate platform designed to create tumor-seeking medicines.

Name
Aktis Oncology, Inc.
CEO
Matthew Roden
Website
www.aktisoncology.com
Industry
Healthcare
Year Founded
2020
Employees
79

Today's Snapshot

AI-generated

AKTS closed 3.2% above yesterday's close, in line with a firmer sector. Trading was lighter than usual, with volume about half of its usual level.

Trading Volume

Below 10d avg (649.1K)

301.6K

vs S&P 500 Today

Strong Outperformance

+3.03%

Updated: September 22, 2026 at 20:28 UTC

Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.